Company Overview

Corporate Profile

Ainos, Inc. (NASDAQ: AIMD) is an AI-driven healthcare and technology company pioneering scent digitization, AI-powered diagnostics, and novel therapeutics.

AI Smell is here. - Ainos’ proprietary AI Nose technology digitizes scent into Smell IDs, enabling AI-powered point-of-care testing (POCT) and applications in robotics, smart manufacturing, senior care, and women’s health. Ainos is advancing commercialization through strategic partnerships, ushering in a new era of digital olfaction.



Ainos also develops VELDONA®, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health, while advancing clinical stage orphan drugs developments.

The name “Ainos” combines “AI” and “Nose”, reflecting its mission to digitize smell, enhance AI capabilities, transform industries, with the ultimate vision of becoming AI’s nose. Ainos is pronounced “iNose”.